Especialitat
Retina i Vitri
Títol complet
A 12-month, Prospective, Open-label, Phase 4 Study to Evaluate the Efficacy and Safety of OZURDEX (Dexamethasone Intravitreal Implant) in Treatment Naïve Patients (According to Standard Clinical Practice) with Diabetic Macular Edema
Promotor
ALLERGAN
Data d'inici
Novembre 2019
Investigadors
Principal: Dr. Rafael Navarro
Co-Investigadors: Dra. Anniken Burés, Dr. Borja Corcóstegui, Dr. Carlos Mateo, Dra. Cecilia Salinas
